Medical device company Medtronic's third quarter fiscal year 2013 net earnings increased by 5.7 percent over the same period in 2012 to $988 million, due in part to growth in cardiac and restorative therapies technology. Net sales also increased from the third quarter of 2012, up 2.8 percent to $4.03 billion. However, overall net earnings dropped slightly over the past nine months from the same period in 2012. Nine-month-end net earnings reached nearly $2.5 billion, down 4.9 percent from 2012's $2.6 billion.
Reported revenue for spine devices also dipped in the third quarter to $753 million, down nearly 4 percent from $784 million in the third quarter 2012.
More Articles on Devices:
OsteoFab Orthopedic Device Receives FDA Clearance
Dr. Richard Kube Performs First Coflex Interlaminar Implant in Illinois
Sports Medicine Device Sales Increase Arthrocare's 4Q Revenue by 4.9%
Reported revenue for spine devices also dipped in the third quarter to $753 million, down nearly 4 percent from $784 million in the third quarter 2012.
More Articles on Devices:
OsteoFab Orthopedic Device Receives FDA Clearance
Dr. Richard Kube Performs First Coflex Interlaminar Implant in Illinois
Sports Medicine Device Sales Increase Arthrocare's 4Q Revenue by 4.9%